<DOC>
	<DOC>NCT00471211</DOC>
	<brief_summary>The purpose of the study is to determine the safety, tolerability and efficacy of 2 doses of PBT2 administered for 12 weeks compared to placebo in patients with early Alzheimer's disease treated with an acetylcholinesterase inhibitor.</brief_summary>
	<brief_title>Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>diagnosis of probable early Alzheimer's disease stable dose of acetylcholinesterase inhibitor community dwelling stable medical condition unstable and significant medical conditions recurrent major psychiatric disorder treatment with memantine</criteria>
	<gender>All</gender>
	<minimum_age>56 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>